EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, PERCF: Percheron Therapeutics Ltd

07 Oct 2025
LAST:

0.0100

CHANGE:
 0.00		OPEN:
0.0100		HIGH:
0.0100		ASK:
0.0000		VOLUME:
100K
CHG(%):
13.04		PREV:
0.0115		LOW:
0.0100		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

COMPANY PROFILE

Name:Percheron Therapeutics Ltd
About:Percheron Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia. The company's lead asset is ATL1102, an antisense oligonucleotide inhibitor of CD49d, which is in Phase IIb clinical trial for the treatment of Duchenne muscular dystrophy, multiple sclerosis, asthma, and other inflammatory indications. It also develops HMBD-002, a recombinant humanised monoclonal IgG4 antibody, which completed Phase I clinical trial to targer v-domain immunoglobulin suppressor of T-cell activation and cancer cells. The company was formerly known as Antisense Therapeutics Limited and changed its name to Percheron Therapeutics Limited in December 2023. Percheron Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Sector:Healthcare
Address:Collins Place, Melbourne, VIC, Australia, 3000
Website:https://percherontx.com
ISIN:AU0000317281
FIGI:BBG000P1Z5D5

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.016.4%
MA10:0.0147.1%
STO9:47.67
Week High:0.010.0%
Week Low:0.010.0%